150 related articles for article (PubMed ID: 37428307)
1. Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.
Wang B; Zhou M; Gan XL; Ren YX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
Int J Clin Oncol; 2023 Sep; 28(9):1147-1157. PubMed ID: 37428307
[TBL] [Abstract][Full Text] [Related]
2. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.
Yokoyama Y; Matsumoto A; Hieda M; Shinchi Y; Ogihara E; Hamada M; Nishioka Y; Kimura H; Yoshidome K; Tsujimoto M; Matsuura N
Breast Cancer Res; 2014 Jun; 16(3):R66. PubMed ID: 24953066
[TBL] [Abstract][Full Text] [Related]
3. H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer.
Xiao CK; Ren Y; Chen Q; Yang Y; Tang L; Xu L; Ren Z
Epigenetics; 2024 Dec; 19(1):2343593. PubMed ID: 38643489
[TBL] [Abstract][Full Text] [Related]
4. Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients.
Wang B; Zhou M; Shi YY; Chen XL; Ren YX; Yang YZ; Tang LY; Ren ZF
Virchows Arch; 2023 Jun; 482(6):1047-1056. PubMed ID: 37059917
[TBL] [Abstract][Full Text] [Related]
5. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
Elsheikh SE; Green AR; Rakha EA; Powe DG; Ahmed RA; Collins HM; Soria D; Garibaldi JM; Paish CE; Ammar AA; Grainge MJ; Ball GR; Abdelghany MK; Martinez-Pomares L; Heery DM; Ellis IO
Cancer Res; 2009 May; 69(9):3802-9. PubMed ID: 19366799
[TBL] [Abstract][Full Text] [Related]
6. SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.
Kapoor-Vazirani P; Kagey JD; Vertino PM
Mol Cell Biol; 2011 Apr; 31(8):1594-609. PubMed ID: 21321083
[TBL] [Abstract][Full Text] [Related]
7. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
8. A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausing.
Kapoor-Vazirani P; Vertino PM
J Biol Chem; 2014 Mar; 289(11):7425-37. PubMed ID: 24459145
[TBL] [Abstract][Full Text] [Related]
9. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
[TBL] [Abstract][Full Text] [Related]
11. Association of H3K9me3 with breast cancer prognosis by estrogen receptor status.
Zhou M; Yan JQ; Chen QX; Yang YZ; Li YL; Ren YX; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
Clin Epigenetics; 2022 Oct; 14(1):135. PubMed ID: 36303253
[TBL] [Abstract][Full Text] [Related]
12. Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer.
Benard A; Goossens-Beumer IJ; van Hoesel AQ; de Graaf W; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
BMC Cancer; 2014 Jul; 14():531. PubMed ID: 25047223
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair.
Li L; Wang Y
J Biol Chem; 2017 Jul; 292(28):11951-11959. PubMed ID: 28546430
[TBL] [Abstract][Full Text] [Related]
14. Loss of histone H4 lysine 20 trimethylation in osteosarcoma is associated with aberrant expression ofhistone methyltransferase SUV420H2.
Piao L; Yuan X; Wang L; Xu X; Zhuang M; Li J; Kong R; Liu Z
Oncol Lett; 2020 Oct; 20(4):26. PubMed ID: 32774499
[TBL] [Abstract][Full Text] [Related]
15. Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity.
Kapoor-Vazirani P; Kagey JD; Powell DR; Vertino PM
Cancer Res; 2008 Aug; 68(16):6810-21. PubMed ID: 18701507
[TBL] [Abstract][Full Text] [Related]
16. Methyl deficiency, alterations in global histone modifications, and carcinogenesis.
Pogribny IP; Tryndyak VP; Muskhelishvili L; Rusyn I; Ross SA
J Nutr; 2007 Jan; 137(1 Suppl):216S-222S. PubMed ID: 17182829
[TBL] [Abstract][Full Text] [Related]
17. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.
Wei Y; Wang F; Sang B; Xu Z; Yang D
Life Sci; 2019 May; 225():55-63. PubMed ID: 30946839
[TBL] [Abstract][Full Text] [Related]
18. Expression of hMOF, but not HDAC4, is responsible for the global histone H4K16 acetylation in gastric carcinoma.
Zhu L; Yang J; Zhao L; Yu X; Wang L; Wang F; Cai Y; Jin J
Int J Oncol; 2015; 46(6):2535-45. PubMed ID: 25873202
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
[TBL] [Abstract][Full Text] [Related]
20. Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer.
Van Den Broeck A; Brambilla E; Moro-Sibilot D; Lantuejoul S; Brambilla C; Eymin B; Gazzeri S
Clin Cancer Res; 2008 Nov; 14(22):7237-45. PubMed ID: 18974389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]